^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    BCMA-BCL2L1-CART

    i
    Other names: BCMA-BCL2L1-CART, BCL2L1 armoured BCMA targeting CAR T
    Associations
    News
    Trials
    Company:
    University of Calgary
    Drug class:
    BCMA-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials